Progressive cerebral atrophy in MS
暂无分享,去创建一个
M N Rossor | Nick C Fox | R J Harvey | W R Crum | A J Thompson | N C Fox | A. Thompson | W. Crum | M. Rossor | N. Losseff | R. Jenkins | R. Harvey | V. Stevenson | S. Leary | D H Miller | S M Leary | V L Stevenson | R Jenkins | N A Losseff | D. Miller | D. Miller | A. Thompson | A. Thompson
[1] T. Hammeke,et al. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. , 1985, Archives of neurology.
[2] Nick C Fox,et al. Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.
[3] U. Roessmann,et al. Analysis of brain weight. II. Adult brain weight in relation to body height, weight, and surface area. , 1980, Archives of pathology & laboratory medicine.
[4] S. Reingold,et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.
[5] D R Fish,et al. Methods for normalization of hippocampal volumes measured with MR. , 1995, AJNR. American journal of neuroradiology.
[6] W. Jagust,et al. Brain atrophy as a surrogate marker in MS , 2000, Neurology.
[7] L D Blumhardt,et al. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis , 1999, Journal of neurology, neurosurgery, and psychiatry.
[8] A J Thompson,et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.
[9] Nick C. Fox,et al. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.
[10] J. Koziol,et al. Cladribine in treatment of chronic progressive multiple sclerosis , 1994, The Lancet.
[11] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[12] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[13] G. Comi,et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis , 1993, Journal of the Neurological Sciences.
[14] Lublin Fd,et al. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .
[15] V. Haughton,et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.
[16] G. Barker,et al. Spinal cord atrophy and disability in MS , 1998, Neurology.
[17] J. Koziol,et al. A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis. , 1999, Proceedings of the Association of American Physicians.
[18] A. Thompson,et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.
[19] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[20] J K Udupa,et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[21] Massimo Filippi,et al. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis , 1998, Journal of the Neurological Sciences.
[22] L Bozzao,et al. SPECT, MRI and cognitive functions in multiple sclerosis. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[23] J V Straumfjord,et al. Analysis of brain weight. I. Adult brain weight in relation to sex, race, and age. , 1980, Archives of pathology & laboratory medicine.
[24] S. Reingold,et al. Defining the clinical course of multiple sclerosis , 1996, Neurology.
[25] Nick C Fox,et al. Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. , 1996, Journal of computer assisted tomography.
[26] M N Rossor,et al. Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. , 2000, Archives of neurology.
[27] P M Matthews,et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.
[28] E D Acheson,et al. Epidemiology of multiple sclerosis. , 1977, British medical bulletin.
[29] D. Li,et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis , 1994, Annals of neurology.
[30] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[31] J. Hajnal,et al. A Registration and Interpolation Procedure for Subvoxel Matching of Serially Acquired MR Images , 1995, Journal of computer assisted tomography.
[32] Nick C Fox,et al. Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.
[33] L D Blumhardt,et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. , 1999, Brain : a journal of neurology.
[34] Nick C Fox,et al. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. , 1997, Computer methods and programs in biomedicine.